Veritas wins European patent for RNA delivery method

Florida-based Veritas Bio won a European patent to cover its delivery technique for RNA-based drugs. The technology enables small pieces of RNA, which can be used to "silence" genetic traits, to reach the liver and treat diseases affecting the organ. The company has a corresponding patent allowed in the U.S. already, and is in the process of filing other applications to expand its RNA-drug capacity, according to a report at HispanicBusiness.com. Inventor Catherine Pachuk told the publication: "Our technology solves one of the biggest hurdles for the development of RNAi and other nucleic acid-based drugs by providing a safe and effective delivery system for effector RNA molecules and other nucleic acid molecules." More

Suggested Articles

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.

Researchers at Johns Hopkins have changed the structure of a new cancer drug to allow it to more easily pass the blood-brain barrier, giving it access to…

Medtronic’s world-first FDA-approved hybrid closed-loop insulin delivery system might soon face competition, as T1D Exchange has pledged to invest in the…